News - 02 Oct `21COVID-19 treatments linked to vitiligo

New

Investigators in Brazil concluded that the severity of acute COVID-19 did not differ among patients with vitiligo, atopic dermatitis, psoriasis and other skin diseases. However, different treatments were linked to specific changes in the course of skin diseases. 

  • Antimalarials and hydroxychloroquine for COVID-19 were associated with clinical worsening of vitiligo. (Actually, antimalarials are oxidative drugs whose additional stress on melanocytes can influence active vitiligo.)
  • Oral corticosteroids for the treatment of vitiligo lead to greater clinical impairment.
  • Antihistamines for dermatological diseases were also associated with a longer symptomatic period in cases of acute COVID-19.
  • Investigators believe the use of oral glucocorticoids, which were used in cases of unstable vitiligo and chronic urticaria, indicated increased exacerbation caused by viral infection.

Overall, hospitalization due to COVID-19 did not differ between respondents with and without skin diseases, though a lower rate of hospitalization was noted for respondents with vitiligo who used oral antioxidants (e.g. vitamin E, vitamin C or Polypodium leucotomos). 

 

Further reading: Am I at higher risk of catching SARS-CoV-2 if I have vitiligo?

 

      FAQOther Questions

      • What is vitiligo?

        Vitiligo (pronounced vit-ill-EYE-go) is a relatively common skin disease characterized by smooth, white, painless spots or patches on various parts of the body and hairs above i...

      • Isn't it just a cosmetic disorder?

        Contrary to popular belief, vitiligo is not a cosmetic disorder but a systemic disease affecting the largest body organ and other vital systems, with multiple comorbidities. Fo...

      • Does halo nevi affect vitiligo development?

        Halo nevi — nevi with an depigmented circle around it, usually on the trunk — are about 10x more common in vitiligo patients than in the general population, especially in childr...